, Tracking Stock Market Picks
Enter Symbol:

down 64.81 %

ATHERSYS INC (ATHX) rated Buy with price target $7 by Lazard Capital

Posted on: Thursday,  Jun 19, 2008  8:25 AM ET by Lazard Capital

Lazard Capital rated Buy ATHERSYS INC (NASDAQ: ATHX) on 06/19/2008, when the stock price was $3.24. Since
then, ATHERSYS INC has lost 64.81% as of 01/26/2016's recent price of $1.14.
If you would have followed this Lazard Capital's recommendation on ATHX, you would have lost 64.81% of your investment in 2777 days.

Athersys, Inc., is a biopharmaceutical company engaged in the discovery and development of therapeutic products. Through the application of its technologies, the Company has established a pipeline of therapeutic product development programs in multiple disease areas. The Company?s current product development portfolio consists of MultiStem, a patented and stem cell product that the Company is developing as a treatment for multiple disease indications, and that is being evaluated in two ongoing clinical trials. In addition, the Company are developing novel pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy or other forms of excessive daytime sleepiness. In December 2008, the Company were granted authorization by the United States Food and Drug Administration (FDA), to initiate a third clinical trial, administering MultiStem for the treatment of ischemic stroke.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/19/2008 8:25 AM Buy
3.24 7.00
as of 12/24/2008
1 Week down  -1.23 %
1 Month up  9.58 %
3 Months   
1 YTD up  77.77 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy